The case report presents the treatment of patient in working age with type 2 diabetes mellitus with modern antidiabetic therapy of single pill combination of linagliptin and metformin. This therapy resulted in massive decrease of glycated hemoglobin without hypoglycemic events.
Single pill combination of linagliptin and metformin was chosen because of better compliance of patients on single pill combination and added benefit of linagliptin molecule in this single pill combination.